Association of HLA-DRB3*0202 and serum IgG antibodies to Chlamydia pneumoniae with essential hypertension in a highly homogeneous population from Majorca (Balearic Islands, Spain)

Journal of Human Hypertension

Volumn 19, Issue 8, 2005, Pages 615-622

  Zabay, J M ^a   Marco, J ^b   Soler, J ^c   Contu, L ^d   Cappai, L ^d   Carcassi, C ^d   Gomez G ^b   Mulet, J M ^c   Munar, M A ^b   Viader, C ^a  

^a Fundacion Balear Transplant Immunogen   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c Laboratorio Inmunogen SL   (Spain)

^d UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Chlamydia pneumoniae; Essential hypertension; Genetics; Infection; Majorca (Balearic Islands); MHC class II

Indexed keywords

HLA B ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G;

ADULT; AGED; ALLELE; ANALYSIS OF VARIANCE; ARTICLE; BACTERIAL INFECTION; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CHI SQUARE TEST; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; GENE LOCUS; GENETIC RISK; GEOGRAPHIC DISTRIBUTION; HLA SYSTEM; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; OBESITY; POPULATION DISTRIBUTION; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SERODIAGNOSIS; SPAIN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

ADULT; AGED; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; HYPERTENSION; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RISK FACTORS; SPAIN;

EID: 23644436548     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001872     Document Type: Article

References (30)

1. Schork NJ. Genetically complex cardiovascular traits: origins, problems, and potential solutions. Hypertension 1997; 29: 145-149.
2. Gerbase-DeLima M et al. Essential hypertension and histocompatibility antigens. A linkage study. Hypertension 1989; 14: 604-609.
3. Vidan-Jeras B et al. Possible influence of genes located on chromosome 6 within or near to the major histo-compatibility complex on development of essential hypertension. Eur J Physiol 2000; 439(Suppl): R60-R62.
4. Patel R, Johnson J. Histocompatibility antigens in black patients with essential hypertension. Circulation 1981; 64: 1042-1044.
5. Luque Otero M et al. Severe hypertension in the Spanish population. Association with specific HLA antigens. Hypertension 1983; 5: V149-152.
6. Gerbase-DeLima M et al. Essential hypertension and histocompatibility antigens. An association study. Hypertension 1992; 19: 400-402.
7. Titkov YS et al. HLA antigens in borderline and essential hypertension. Am J Hypertens 1993; 6: 885-887.
8. Gerbase-DeLima M et al. Human leukocyte antigens and malignant essential hypertension. Am J Hypertens 1998; 11: 729-731.
9. Nishimura M et al. Inverse association of Chlamydia pneumoniae infection with high blood pressure in Japanese adults. Am J Hypertens 2001; 14: 20-26.
10. Cook PJ et al. Chlamydia pneumoniae antibodies in severe essential hypertension. Hypertension 1998; 31: 589-594.
11. Pitiriga VC et al. Increased prevalence of Chlamydophila pneumoniae but not Epstein-Barr antibodies in essential hypertensives. J Hum Hypertens 2003; 17: 21-27.
12. Pitiriga VC et al. High prevalence of Chlamydia pneumoniae antibodies in white-coat hypertensives. Atherosclerosis 2003; 167: 231-235.
13. Grayston JT. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 2000; 181(Suppl 3): S402-S410.
14. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
15. Kunz R et al. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997; 30: 1331-1337.
16. Zabay-Becerril JM et al. The relation between the HLA-DRB1*1501 allele and severity of multiple sclerosis in a sample of the Spanish population from the Balearic Islands: the influence exerted by sex. Rev Neurol 2004; 38: 118-122.
17. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995; 310: 170.
18. Neumann F-J et al. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial. Lancet 2001; 357: 2085-2089.
19. Mendall MA et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 1995; 30: 121-128.
20. Gupta S et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96: 404-407.
21. Mosorin M et al. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler Thromb Vasc Biol 2000; 20: 1061-1067.
22. Wentworth P et al. Evidence for ozone formation in human atherosclerotic arteries. Science 2003; 302: 1053-1056.
23. Saikku P. Chlamydia pneumoniae and atherosclerosis: un update. Scand J Infect Dis 1997; 104: 53-56.
24. Kol A, Sukhova GK, Lichtman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression. Circulation 1998; 98: 300-307.
25. Halme S, Saikku P, Surcel H-M. Characterization of Chlamydia pneumoniae antigens using human T cell clones. Scand J Immunol 1997; 45: 378-384.
26. Brasier AR, Li J, Wimbish KA. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension 1996; 27: 1009-1017.
27. Sasamura H et al. Regulation of vascular type 1 angiotensinogen receptors by cytokines. Hypertension 1997; 30: 35-41.
28. Peeters ACTM et al. Pro-inflammatory cytokines in patients with essential hypertension. Eur J Clin Invest 2001; 31: 31-36.
29. Gaur LK et al. Association of Chlamydia trachomatis heat-shock protein 60 antibody and HLA class II DQ alleles. J Infect Dis 1999; 180: 234-237.
30. Yoshitake S, Okada M, Kimura A, Sasazuki T. Contribution of major histocompatibility complex genes to susceptibility and resistance in Helicobacter pylori related diseases. Eur J Gastroenterol Hepatol 1999; 11: 875-880.